These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 202522)

  • 41. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
    Mills BJ; Beebe DP; Cooper NR
    J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.
    Zinkernagel RM; Althage A; Cooper S; Kreeb G; Klein PA; Sefton B; Flaherty L; Stimpfling J; Shreffler D; Klein J
    J Exp Med; 1978 Aug; 148(2):592-606. PubMed ID: 212503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective and unidirectional membrane redistribution of an H-2 antigen with an antibody-clustered viral antigen: relationship to mechanisms of cytotoxic T-cell interactions.
    Geiger B; Rosenthal KL; Klein J; Zinkernagel RM; Singer SJ
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4603-7. PubMed ID: 228303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Limitation of VSV infection by the host's response to VSV-associated cellular antigens.
    Hecht TT; Paul WE
    J Immunol; 1982 Oct; 129(4):1736-41. PubMed ID: 6180021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Replication of vesicular stomatitis virus in mouse spleen cells.
    Hecht TT; Paul WE
    Infect Immun; 1981 Jun; 32(3):1014-23. PubMed ID: 6265370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity in mice of temperature-sensitive mutants of vesicular stomatitis virus: early appearance in bronchial secretions of an interferon-like inhibitor.
    Beatrice ST; Wagner RR
    J Gen Virol; 1980 Apr; 47(2):529-33. PubMed ID: 6154132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virus-induced non-specific signals cause cell cycle progression of primed CD8(+) T cells but do not induce cell differentiation.
    Andreasen SO; Christensen JP; Marker O; Thomsen AR
    Int Immunol; 1999 Sep; 11(9):1463-73. PubMed ID: 10464167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen processing of vesicular stomatitis virus in situ. Interdigitating dendritic cells present viral antigens independent of marginal dendritic cells but fail to prime CD4(+) and CD8(+) T cells.
    Ciavarra RP; Greene AR; Horeth DR; Buhrer K; van Rooijen N; Tedeschi B
    Immunology; 2000 Dec; 101(4):512-20. PubMed ID: 11122455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system.
    Bi Z; Quandt P; Komatsu T; Barna M; Reiss CS
    J Immunol; 1995 Dec; 155(12):5684-9. PubMed ID: 7499854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.
    Marsac D; Loirat D; Petit C; Schwartz O; Michel ML
    J Virol; 2002 Aug; 76(15):7544-53. PubMed ID: 12097567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thymic selection of H-2-incompatible bone marrow cells in SCID mice. Differences in T help for induction of B cell IgG responses versus cytotoxic T cells.
    Zinkernagel RM; Rüedi E; Althage A; Hengartner H; Reimann G
    J Exp Med; 1988 Sep; 168(3):1187-92. PubMed ID: 2971754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?
    Zinkernagel RM; Haenseler E; Leist T; Cerny A; Hengartner H; Althage A
    J Exp Med; 1986 Oct; 164(4):1075-92. PubMed ID: 3489805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of an immunoelectroosmophoresis test for the detection and typing of antibodies to vesicular stomatitis viruses.
    Wilks CR; Jenney EW; House JA
    Can J Comp Med; 1984 Apr; 48(2):179-83. PubMed ID: 6326981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diminution by vesicular stomatitis virus of acute graft vs host mortality in mice.
    Umetsu DT; Romano TJ; Bloom BR; Thorbecke GJ
    Cell Immunol; 1979 Sep; 46(2):416-21. PubMed ID: 39680
    [No Abstract]   [Full Text] [Related]  

  • 56. Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice. II. Immunofluorescent, morphologic, and immunologic studies.
    Dal Canto MC; Rabinowitz SG; Johnson TC
    J Infect Dis; 1979 Jan; 139(1):36-51. PubMed ID: 220329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus.
    McAdam AJ; Farkash EA; Gewurz BE; Sharpe AH
    J Virol; 2000 Jan; 74(1):203-8. PubMed ID: 10590107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.
    Nowakowski M; Feldman JD; Kano S; Bloom BR
    J Exp Med; 1973 Apr; 137(4):1042-59. PubMed ID: 4348276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection.
    Maloy KJ; Burkhart C; Freer G; Rülicke T; Pircher H; Kono DH; Theofilopoulos AN; Ludewig B; Hoffmann-Rohrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Mar; 162(5):2867-74. PubMed ID: 10072535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-reactive cytotoxic T cells to serologically distinct vesicular stomatitis virus.
    Rosenthal KL; Zinkernagel RM
    J Immunol; 1980 May; 124(5):2301-8. PubMed ID: 6154097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.